Page 9 - ஜப்பானிய ஆரோக்கியம் அமைச்சகம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

India s Dr.Reddy s ends study of COVID-19 drug Avigan in Kuwait Reuters 27/01/2021 © Reuters/Issei Kato FILE PHOTO: Tablets of Avigan are displayed during a photo opportunity at Fujifilm s headquarters in Tokyo BENGALURU (Reuters) - Indian drugmaker Dr.Reddy s Laboratories said on Wednesday it had terminated its clinical study of Fujifilm Holdings COVID-19 treatment Avigan in patients with moderate to severe symptoms in Kuwait. Data from the Kuwait trial, conducted in partnership with United Arab Emirates-based medical alliance Global Response Aid FZCO (GRA), showed that the difference in time taken by Avigan and placebo to resolve a sustained absence of oxygen in the tissues was not significant enough to continue the trial. (https://bit.ly/3onNbij)

United statesAmy caren danielAnuron kumar mitraFujifilm holdingJapanese health ministryGlenmark pharmaceuticalsIssei katoUnited arab emirates basedGlobal response aidAppili therapeuticsNorth americanஒன்றுபட்டது மாநிலங்களில்ஆமி கவனிப்பு டேனியல்புஜிஃபில்ம் வைத்திருத்தல்ஜப்பானிய ஆரோக்கியம் அமைச்சகம்க்ளேண்மர்க் மருந்துகள்